An early-stage privately held gene therapy company needs licensing and partnering expertise for their groundbreaking platform technologies. A TCG partner, with extensive biopharmaceutical licensing and strategic transactions experience, serves in an interim leadership role, including development and implementation of licensing…
A regional EU government-driven initiative called for licensing and partnering of early and mid-stage assets with US companies. A TCG Partner evaluated the technologies, reviewed literature, met with inventors, wrote technology memoranda and conducted research to identify well-funded, good-fit prospective…
A US based, market leading diagnostics company wanted to expand its product line in Europe where it was a second-tier player. TCG met US and EU managers to define the key search parameters. Through its broad network, TCG identified more…
A European public company with orthopedic medical devices wanted to enter the US market but had no established American distributors. TCG identified distributors in two key market segments (spinal applications, and general orthopedics) and negotiated two segment-specific distribution contracts on…